Research on strategy of China pharmaceutical companies coping with competition of authorized generics in American drug market
- Author:
Li-Chun LIU
1
Author Information
- Publication Type:Journal Article
- Keywords: Authorized generics; Brand-name drug; Independent generics; Patent strategy
- From: Chinese Pharmaceutical Journal 2013;48(14):1217-1222
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To study the principle, feature and impact of the authorized generics strategy in American drug market, thus to provide some references for Chinese scholars who research the authorized generics strategy and for China pharmaceutical companies that would face competition in American pharmaceutical market. METHODS: By case study and policies analysis, the ways how the brand-name companies used the authorized generics in American drug market were summarized. RESULTS and CONCLUSION: Successful authorized generics strategy can maintain a large market share of the brand-name companies products. In American drug market, there are some particularities about the authorize generics strategy due to the features of American drug policies and regulations. China pharmaceutical companies should implement different authorized generics strategy according to their own conditions in American drug market at present.
